Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Genome and transcriptome study of the response to irinotecan and bevacizumab in recurrent glioblastomas (CIT - Homo sapiens - BEVA)


ABSTRACT: A Cartes d'Identite des Tumeurs (CIT) project from the French National League Against Cancer (http://cit.ligue-cancer.net ) 25 glioblastoma multiforme tumors hybridized on Illumina SNP and Affymetrix gene expression arrays. Project leader : François DUCRAY (francois.ducray@chu-lyon.fr). CIT Analysis : Julien LAFFAIRE (laffairej@ligue-cancer.net). Note: PFS : progression-free survival, OS: Overall Survival,BCNU : Carmustine (chemotherapy agent). RESPONDER: if the patient has shown or not shown a response to the treatment (Bevacizumab (Avastin) plus Irinotecan). Progression during : If the disease has progressed (cancer relapse or patient's death); otherwise (patient is alive without relapse).

ORGANISM(S): Homo sapiens

SUBMITTER: Fabien PETEL 

PROVIDER: E-MTAB-951 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications


<h4>Background</h4>We performed a retrospective study to assess whether the initial molecular characteristics of glioblastomas (GBMs) were associated with the response to the bevacizumab/irinotecan chemotherapy regimen given at recurrence.<h4>Results</h4>Comparison of the genomic and gene expression profiles of the responders (n = 12) and nonresponders (n = 13) demonstrated only slight differences and could not identify any robust biomarkers associated with the response. In contrast, a significa  ...[more]

Similar Datasets

2012-10-19 | E-MTAB-923 | biostudies-arrayexpress
2007-05-05 | E-TABM-117 | biostudies-arrayexpress
2012-02-01 | E-MTAB-748 | biostudies-arrayexpress
2010-07-07 | E-TABM-898 | biostudies-arrayexpress
2011-07-28 | E-TABM-1169 | biostudies-arrayexpress
2011-09-30 | E-MTAB-638 | biostudies-arrayexpress
2009-01-15 | E-TABM-311 | biostudies-arrayexpress
2015-01-01 | E-MTAB-1940 | biostudies-arrayexpress
2007-08-23 | E-TABM-302 | biostudies-arrayexpress
2007-03-26 | E-TABM-36 | biostudies-arrayexpress